2024. Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer. Biomolecules and Biomedicine. 24, 2 (Mar. 2024), 346–359. DOI:https://doi.org/10.17305/bb.2023.9489.